We are live on ! Find out more
ALT icon

Altimmune
ALT

110 hedge funds and large institutions have $467M invested in Altimmune in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

647% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $1.75M

600% more funds holding in top 10

Funds holding in top 10: 1 → 7 (+6)

125% more capital invested

Capital invested by funds: $207M → $467M (+$260M)

27% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 30

14.47% more ownership

Funds ownership: 77.86% → 92.33% (+14%)

7% more funds holding

Funds holding: 103 → 110 (+7)

13% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 31

Holders
110
Holders Change
+7
Holders Change %
+6.8%
% of All Funds
1.85%
Holding in Top 10
7
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+600%
% of All Funds
0.12%
New
38
Increased
27
Reduced
31
Closed
30
Calls
$13.1M
Puts
$1.75M
Net Calls
+$11.4M
Net Calls Change
+$6.91M

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$18.5M
2
TCM
Tang Capital Management
California
+$6.33M
3
BBA
Baker Bros. Advisors
New York
+$6.19M
4
DCM
Driehaus Capital Management
Illinois
+$5.8M
5
IC
Ikarian Capital
Texas
+$5.53M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$12.2M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.92M
3
State Street
State Street
Massachusetts
-$3.43M
4
VA
VR Adviser
New York
-$2.41M
5
WP
Woodline Partners
California
-$1.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
26
Atika Capital Management
New York
$4.81M +$2.53M +411,039 New
Geode Capital Management
27
Geode Capital Management
Massachusetts
$4.44M -$1.62M -261,990 -41%
VA
28
VR Adviser
New York
$4.32M -$2.41M -390,413 -51%
AllianceBernstein
29
AllianceBernstein
Tennessee
$4.1M -$891K -144,535 -29%
DA
30
DCF Advisers
Connecticut
$3.92M +$118K +19,180 +6%
ECM
31
ExodusPoint Capital Management
New York
$3.58M +$1.72M +279,528 +1,061%
BWCS
32
Beirne Wealth Consulting Services
Connecticut
$3.33M +$622K +100,807 +55%
Marshall Wace
33
Marshall Wace
United Kingdom
$3.16M +$1.67M +270,330 New
E
34
Ergoteles
New York
$2.51M +$1.32M +214,700 New
Balyasny Asset Management
35
Balyasny Asset Management
Illinois
$2.42M +$1.27M +206,469 New
EI
36
EAM Investors
California
$2.27M +$1.2M +194,271 New
Norges Bank
37
Norges Bank
Norway
$2.22M – – –
Group One Trading
38
Group One Trading
Illinois
$2.21M +$861K +139,668 +283%
TIM
39
Timelo Investment Management
Ontario, Canada
$2.19M +$1.16M +187,529 New
SSA
40
Schonfeld Strategic Advisors
New York
$2.09M +$1M +162,500 +985%
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$1.99M -$4.92M -798,053 -82%
JP Morgan Chase
42
JP Morgan Chase
New York
$1.88M -$907K -147,016 -48%
SAM
43
Sectoral Asset Management
Quebec, Canada
$1.75M +$925K +150,000 New
State Street
44
State Street
Massachusetts
$1.59M -$3.43M -555,595 -80%
Walleye Capital
45
Walleye Capital
New York
$1.58M -$473K -76,760 -36%
KCM
46
Knoll Capital Management
Florida
$1.56M – – –
BFM
47
Boothbay Fund Management
New York
$1.5M +$791K +128,283 New
EGI
48
EAM Global Investors
California
$1.47M +$777K +125,995 New
Simplex Trading
49
Simplex Trading
Illinois
$1.47M +$772K +125,262 New
Dimensional Fund Advisors
50
Dimensional Fund Advisors
Texas
$1.44M +$312K +50,662 +70%
1
2
3 4 5

ALT Hedge Fund Activity: Q2 2022 in Review

110 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q2 2022, worth a combined $467M — up 125% from $207M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new ALT positions and 30 closed out — a net gain of 8 holders — while 27 added to existing stakes and 31 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $18.5M. The largest seller was BlackRock, cutting an estimated $12.2M.

  • 110 institutional investors held Altimmune (ALT) as of Q2 2022, up from 103 in Q1 2022.
  • Funds reported $467M of Altimmune stock for Q2 2022, up 125% quarter-over-quarter.
  • 38 funds opened new Altimmune positions in Q2 2022 and 30 closed out, a net change of +8 holders.
  • The largest Altimmune buyer in Q2 2022 was Cormorant Asset Management, an estimated $18.5M added.
  • The largest Altimmune seller in Q2 2022 was BlackRock, an estimated $12.2M sold.

Based on aggregated 13F filings for Q2 2022.